Benactyzine is an anticholinergic drug used as an antidepressant in the treatment of depression and associated anxiety.
Benactyzine is no longer widely used in medicine, although it is still a useful drug for scientific research. It does not possess any antihistamine properties.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Buprenorphine | Benactyzine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine. |
| Doxylamine | Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Benactyzine. |
| Dronabinol | Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Benactyzine. |
| Droperidol | Droperidol may increase the central nervous system depressant (CNS depressant) activities of Benactyzine. |
| Hydrocodone | Benactyzine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone. |
| Hydroxyzine | Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Benactyzine. |
| Magnesium sulfate | The therapeutic efficacy of Benactyzine can be increased when used in combination with Magnesium sulfate. |
| Methotrimeprazine | Benactyzine may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine. |
| Metyrosine | Benactyzine may increase the sedative activities of Metyrosine. |
| Minocycline | Minocycline may increase the central nervous system depressant (CNS depressant) activities of Benactyzine. |
| Mirtazapine | Benactyzine may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine. |
| Nabilone | Nabilone may increase the central nervous system depressant (CNS depressant) activities of Benactyzine. |
| Orphenadrine | Benactyzine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
| Paraldehyde | Benactyzine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde. |
| Perampanel | Perampanel may increase the central nervous system depressant (CNS depressant) activities of Benactyzine. |
| Pramipexole | Benactyzine may increase the sedative activities of Pramipexole. |
| Ropinirole | Benactyzine may increase the sedative activities of Ropinirole. |
| Rotigotine | Benactyzine may increase the sedative activities of Rotigotine. |
| Rufinamide | The risk or severity of adverse effects can be increased when Rufinamide is combined with Benactyzine. |
| Sodium oxybate | Benactyzine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Suvorexant | Benactyzine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
| Tapentadol | Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Benactyzine. |
| Thalidomide | Benactyzine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
| Zolpidem | Benactyzine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
| Aclidinium | The risk or severity of adverse effects can be increased when Benactyzine is combined with Aclidinium. |
| Mianserin | Mianserin may increase the anticholinergic activities of Benactyzine. |
| Mirabegron | The risk or severity of urinary retention can be increased when Benactyzine is combined with Mirabegron. |
| Potassium chloride | The risk or severity of gastrointestinal ulceration can be increased when Benactyzine is combined with Potassium chloride. |
| Pramlintide | The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Benactyzine. |
| Secretin porcine | The therapeutic efficacy of Secretin porcine can be decreased when used in combination with Benactyzine. |
| Tiotropium | The risk or severity of adverse effects can be increased when Benactyzine is combined with Tiotropium. |
| Topiramate | The risk or severity of hyperthermia and oligohydrosis can be increased when Benactyzine is combined with Topiramate. |
| Umeclidinium | The risk or severity of adverse effects can be increased when Benactyzine is combined with Umeclidinium. |
| Methadone | The risk or severity of adverse effects can be increased when Methadone is combined with Benactyzine. |
| Glycopyrronium | The risk or severity of adverse effects can be increased when Benactyzine is combined with Glycopyrronium. |
| Dicoumarol | The risk or severity of adverse effects can be increased when Benactyzine is combined with Dicoumarol. |
| Phenindione | The risk or severity of adverse effects can be increased when Benactyzine is combined with Phenindione. |
| Warfarin | The risk or severity of adverse effects can be increased when Benactyzine is combined with Warfarin. |
| Phenprocoumon | The risk or severity of adverse effects can be increased when Benactyzine is combined with Phenprocoumon. |
| Acenocoumarol | The risk or severity of adverse effects can be increased when Benactyzine is combined with Acenocoumarol. |
| 4-hydroxycoumarin | The risk or severity of adverse effects can be increased when Benactyzine is combined with 4-hydroxycoumarin. |
| Coumarin | The risk or severity of adverse effects can be increased when Benactyzine is combined with Coumarin. |
| (R)-warfarin | The risk or severity of adverse effects can be increased when Benactyzine is combined with (R)-warfarin. |
| Ethyl biscoumacetate | The risk or severity of adverse effects can be increased when Benactyzine is combined with Ethyl biscoumacetate. |
| Fluindione | The risk or severity of adverse effects can be increased when Benactyzine is combined with Fluindione. |
| Clorindione | The risk or severity of adverse effects can be increased when Benactyzine is combined with Clorindione. |
| Diphenadione | The risk or severity of adverse effects can be increased when Benactyzine is combined with Diphenadione. |
| Tioclomarol | The risk or severity of adverse effects can be increased when Benactyzine is combined with Tioclomarol. |
| (S)-Warfarin | The risk or severity of adverse effects can be increased when Benactyzine is combined with (S)-Warfarin. |
| Botulinum toxin type A | The risk or severity of adverse effects can be increased when Benactyzine is combined with Botulinum toxin type A. |
| Glucagon | Benactyzine may increase the gastrointestinal motility reducing activities of Glucagon. |
| Sulpiride | Benactyzine may increase the anticholinergic activities of Sulpiride. |
| Botulinum toxin type B | The risk or severity of adverse effects can be increased when Benactyzine is combined with Botulinum toxin type B. |
| Eluxadoline | The risk or severity of constipation can be increased when Benactyzine is combined with Eluxadoline. |
| Ramosetron | The risk or severity of constipation can be increased when Benactyzine is combined with Ramosetron. |
| Ethanol | Benactyzine may increase the central nervous system depressant (CNS depressant) activities of Ethanol. |
| Azelastine | Benactyzine may increase the central nervous system depressant (CNS depressant) activities of Azelastine. |
| Brimonidine | Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Benactyzine. |
| Zimelidine | The risk or severity of adverse effects can be increased when Benactyzine is combined with Zimelidine. |
| Dapoxetine | The risk or severity of adverse effects can be increased when Benactyzine is combined with Dapoxetine. |
| Seproxetine | The risk or severity of adverse effects can be increased when Benactyzine is combined with Seproxetine. |
| Fluvoxamine | The risk or severity of adverse effects can be increased when Benactyzine is combined with Fluvoxamine. |
| Citalopram | The risk or severity of adverse effects can be increased when Benactyzine is combined with Citalopram. |
| Duloxetine | The risk or severity of adverse effects can be increased when Benactyzine is combined with Duloxetine. |
| Trazodone | The risk or severity of adverse effects can be increased when Benactyzine is combined with Trazodone. |
| Paroxetine | The risk or severity of adverse effects can be increased when Benactyzine is combined with Paroxetine. |
| Sertraline | The risk or severity of adverse effects can be increased when Benactyzine is combined with Sertraline. |
| Sibutramine | The risk or severity of adverse effects can be increased when Benactyzine is combined with Sibutramine. |
| Nefazodone | The risk or severity of adverse effects can be increased when Benactyzine is combined with Nefazodone. |
| Escitalopram | The risk or severity of adverse effects can be increased when Benactyzine is combined with Escitalopram. |
| Milnacipran | The risk or severity of adverse effects can be increased when Benactyzine is combined with Milnacipran. |
| Desvenlafaxine | The risk or severity of adverse effects can be increased when Benactyzine is combined with Desvenlafaxine. |
| Levomilnacipran | The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Benactyzine. |
| Indalpine | The risk or severity of adverse effects can be increased when Benactyzine is combined with Indalpine. |
| Ritanserin | The risk or severity of adverse effects can be increased when Benactyzine is combined with Ritanserin. |
| Alaproclate | The risk or severity of adverse effects can be increased when Benactyzine is combined with Alaproclate. |
| Naltrexone | The risk or severity of adverse effects can be increased when Benactyzine is combined with Naltrexone. |
| Bezitramide | The risk or severity of adverse effects can be increased when Benactyzine is combined with Bezitramide. |
| Desomorphine | The risk or severity of adverse effects can be increased when Benactyzine is combined with Desomorphine. |
| Nicomorphine | The risk or severity of adverse effects can be increased when Benactyzine is combined with Nicomorphine. |
| Morphine | The risk or severity of adverse effects can be increased when Benactyzine is combined with Morphine. |
| Codeine | The risk or severity of adverse effects can be increased when Benactyzine is combined with Codeine. |
| Hydromorphone | The risk or severity of adverse effects can be increased when Benactyzine is combined with Hydromorphone. |
| Meperidine | The risk or severity of adverse effects can be increased when Benactyzine is combined with Meperidine. |
| Oxycodone | The risk or severity of adverse effects can be increased when Benactyzine is combined with Oxycodone. |
| Butorphanol | The risk or severity of adverse effects can be increased when Benactyzine is combined with Butorphanol. |
| Dextropropoxyphene | The risk or severity of adverse effects can be increased when Benactyzine is combined with Dextropropoxyphene. |
| Pentazocine | The risk or severity of adverse effects can be increased when Benactyzine is combined with Pentazocine. |
| Sufentanil | The risk or severity of adverse effects can be increased when Benactyzine is combined with Sufentanil. |
| Alfentanil | The risk or severity of adverse effects can be increased when Benactyzine is combined with Alfentanil. |
| Fentanyl | The risk or severity of adverse effects can be increased when Benactyzine is combined with Fentanyl. |
| Nalbuphine | The risk or severity of adverse effects can be increased when Benactyzine is combined with Nalbuphine. |
| Levorphanol | The risk or severity of adverse effects can be increased when Benactyzine is combined with Levorphanol. |
| Remifentanil | The risk or severity of adverse effects can be increased when Benactyzine is combined with Remifentanil. |
| Diphenoxylate | The risk or severity of adverse effects can be increased when Benactyzine is combined with Diphenoxylate. |
| Oxymorphone | The risk or severity of adverse effects can be increased when Benactyzine is combined with Oxymorphone. |
| Dezocine | The risk or severity of adverse effects can be increased when Benactyzine is combined with Dezocine. |
| Levacetylmethadol | The risk or severity of adverse effects can be increased when Benactyzine is combined with Levacetylmethadol. |
| Methadyl acetate | The risk or severity of adverse effects can be increased when Benactyzine is combined with Methadyl acetate. |
| Dihydroetorphine | The risk or severity of adverse effects can be increased when Benactyzine is combined with Dihydroetorphine. |